Scholarlink

Background <p>Diabetes mellitus is strongly associated with peripheral arterial disease and foot ulceration, frequently requiring revascularisation to promote wound healing. Percutaneous transluminal angioplasty (PTA) is widely used for infrapopliteal arterial disease; however, its effectiveness for ulcer healing compared with alternative strategies remains uncertain.</p> Objective <p>To assess the effects of PTA in infrapopliteal arterial disease for diabetic ulcer healing.</p> Methods <p>We conducted a systematic review of randomised controlled trials identified through MEDLINE, Embase, LILACS, CENTRAL, CINAHL, ClinicalTrials.gov, the World Health Organisation International Clinical Trials Registry Platform, and grey literature sources. Study selection and data extraction were performed independently. Risk of bias was assessed using the Cochrane Risk of Bias tool. Meta-analyses were undertaken where appropriate, and certainty of evidence was evaluated.</p> Results <p>Of 34 542 records screened, six randomised controlled trials (945 total participants) were included. Compared with venous bypass, PTA was associated with a higher likelihood of ulcer healing (risk ratio 1.20; 95% confidence interval 1.07–1.33; <i>p</i> = .0001; low-certainty evidence). No statistically significant differences were observed between revascularisation strategies for mortality or major amputation. Similarly, no significant differences were identified in comparisons of PTA versus drug-coated balloon or drug-coated stent interventions.</p> Conclusion <p>PTA may be associated with improved arterial ulcer healing compared with venous bypass in patients with diabetes, without clear differences in mortality or amputation rates. However, the certainty of evidence is low, and these findings should be interpreted with caution. Further adequately powered randomised trials are required to clarify the comparative effectiveness of infrapopliteal revascularisation strategies.</p> Graphical abstract <p></p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Endovascular Treatment of Infrapopliteal Arterial Disease in Patients with Diabetic Foot Ulcer: A Systematic Review of Randomised Controlled Trials

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年4月23日

查看全文
  • Carolina Dutra Queiroz Flumignan,
  • Vinicius Cardoso de Farias,
  • Fabio Cabral Freitas Amaral,
  • Ronald Luiz Gomes Flumignan,
  • Luis Carlos Uta Nakano,
  • José Carlos Costa Baptista-Silva

摘要

Background

Diabetes mellitus is strongly associated with peripheral arterial disease and foot ulceration, frequently requiring revascularisation to promote wound healing. Percutaneous transluminal angioplasty (PTA) is widely used for infrapopliteal arterial disease; however, its effectiveness for ulcer healing compared with alternative strategies remains uncertain.

Objective

To assess the effects of PTA in infrapopliteal arterial disease for diabetic ulcer healing.

Methods

We conducted a systematic review of randomised controlled trials identified through MEDLINE, Embase, LILACS, CENTRAL, CINAHL, ClinicalTrials.gov, the World Health Organisation International Clinical Trials Registry Platform, and grey literature sources. Study selection and data extraction were performed independently. Risk of bias was assessed using the Cochrane Risk of Bias tool. Meta-analyses were undertaken where appropriate, and certainty of evidence was evaluated.

Results

Of 34 542 records screened, six randomised controlled trials (945 total participants) were included. Compared with venous bypass, PTA was associated with a higher likelihood of ulcer healing (risk ratio 1.20; 95% confidence interval 1.07–1.33; p = .0001; low-certainty evidence). No statistically significant differences were observed between revascularisation strategies for mortality or major amputation. Similarly, no significant differences were identified in comparisons of PTA versus drug-coated balloon or drug-coated stent interventions.

Conclusion

PTA may be associated with improved arterial ulcer healing compared with venous bypass in patients with diabetes, without clear differences in mortality or amputation rates. However, the certainty of evidence is low, and these findings should be interpreted with caution. Further adequately powered randomised trials are required to clarify the comparative effectiveness of infrapopliteal revascularisation strategies.

Graphical abstract